News
-
-
PRESS RELEASE
VIB Vermögen AG: Early extension of lease agreement with AUMOVIO in Ingolstadt
VIB Vermögen AG extends lease agreement with AUMOVIO in Ingolstadt for a modern office and production building, reinforcing operational success. The property is located close to the city center with a total lettable area of 21,300 m² -
-
-
PRESS RELEASE
Leclanché SA annonce une dérogation temporaire à l’obligation de publication relative à son rapport annuel 2025
Leclanché SA annonce une dérogation temporaire à l’obligation de publication relative à son rapport annuel 2025. Le Comité des Émetteurs a approuvé un report jusqu’au 31 juillet 2026 -
PRESS RELEASE
Leclanché SA announces Temporary Exemption from the Disclosure Obligation in connection with the Publication and the Filing of the 2025 Annual Report
Leclanché SA announces temporary exemption from the disclosure obligation in connection with the publication and filing of the 2025 annual report -
-
PRESS RELEASE
Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
Onco-Innovations starts process development & scale-up activities for A83B4C63, advancing towards clinical trials. Collaboration with Dalton Pharma Services to optimize production processes and ensure regulatory readiness -
-
PRESS RELEASE
Terms of availability of the preparatory documents for the GM
ABL Diagnostics (ABLD) discloses information on total voting rights and share capital composition as per regulatory requirements. The company specializes in molecular biology tests and global solutions for academic labs, private labs, and researchers